IFN-γ-Inducible Chemokines Enhance Adaptive Immunity and Colitis

Journal of Interferon and Cytokine Research

Volumn 23, Issue 10, 2003, Pages 591-600

  Singh, Udai P ^a   Singh, Shailesh ^a   Iqbal, Nuzhat ^b   Weaver, Casey T ^c   McGhee, Jerry R ^d   Lillard Jr , James W ^a,e  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON INDUCIBLE T CELL ALPHA CHEMOATTRACTANT; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; COLITIS; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CHEMOKINES; COLITIS; CROHN DISEASE; FEMALE; GENE DELETION; IMMUNITY, MUCOSAL; INTERFERON TYPE II; LIGANDS; MICE; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CHEMOKINE;

ANIMALIA; MURINAE;

EID: 0142187262     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999003322485099     Document Type: Article

References (66)

1. ELSON, C.O., SARTOR, R.B., TENNYSON, G.S., and RIDDELL, R.H. (1995). Experimental models of inflammatory bowel disease. Gastroenterology 109, 1344-1367.
2. HOLLANDER, G.A., SIMPSON, S.J., MIZOGUCHI, E., NICHOGIANNOPOULOU, A., SHE, J., GUTIERREZ-RAMOS, J.C., BHAN, A.K., BURAKOFF, S.J., WANG, B., and TERHORST, C. (1995). Severe colitis in mice with aberrant thymic selection. Immunity 3, 27-38.
3. KUHN, R., LOHLER, J., RENNICK, D., RAJEWSKY, K., and MULLER, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
4. MOMBAERTS, P., MIZOGUCHI, E., GRUSBY, M.J., GLIMCHER, L.H., BHAN, A.K., and TONEGAWA, S. (1993). Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75, 274-282.
5. POWRIE, F., and LEACH, M.W. (1995). Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther. Immunol. 2, 115-123.
6. SADLACK, B., MERZ, H., SCHORLE, H., SCHIMPL, A., FELLER, A.C., and HORAK, I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253-261.
7. BLUMBERG, R.S., SAUBERMANN, L.J., and STROBER, W. (1999). Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11, 648-656.
8. + T cells. J. Exp. Med. 178, 237-244.
9. FIOCCHI, C. (1998). Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115, 182-205.
10. FUSS, I.J., EHRHARDT, R.O., NEURATH, M., BOIRIVANT, M., LUDVIKSSON, B.R., and STROBER, W. (1998). The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Scand. J. Immunol. 48, 453-458.
11. MONTELEONE, G. (1998). Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7. Gut 43, 735-736.
12. + T cells. Immunity 1, 553-562.
13. + T cells, but not B cells, mediate colitis in interleukin-10- deficient mice. J. Exp. Med. 184, 241-251.
14. STUBER, E.R., STROBER, W., and NEURATH, M.F. (1995). Antibodies to interleukin 12 abrogate established experimental colitis in mice. Immunol. Today 16, 564-569.
15. MITSUYAMA, K., TOYONAGA, A., SASAKI, E., WATANABE, K., TATEISHI, H., NISHIYAMA, T., SAIKI, T., IKEDA, H., TSURUTA, O., and TANIKAWA, K. (1994). IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 96, 432-436.
16. RAAB, Y., GERDIN, B., AHLSTEDT, S., and HALLGREN, R. (1993). Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 34, 1203-1206.
17. AGACE, W.W., ROBERTS, A.I., WU, L., GREINEDER, C., EBERT, E.G., and PARKER, C.M. (2000). Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur. J. of Immunol. 30, 819-826.
18. FARBER, J.M. (1997). MIG and IP-10 - CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61, 246-257.
19. GASPERINI, S., MARCHI, M., CALZETTI, F., LAUDANNA, C., VICENTINI, L., OLSEN, H., MURPHY, M., LIAO, F., FARBER, J., and CASSATELLA, M.A. (1999). Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162, 4928-4937.
20. HAMILTON, N.H., BANYER, J.L., HAPEL, A.J., MAHALINGAM, S., RAMSAY, A.J., RAMSHAW, I.A., and THOMSON, S.A. (2002). IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE). Scand. J. Immunol. 55, 171-177.
21. KOLIOS, G., WRIGHT, K.L., JORDAN, N.J., LEITHEAD, J.B., ROBERTSON, D.A., and WESTWICK, J. (1999). C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur. J. Immunol. 29, 530-536.
22. LUSTER, A.D., and RAVETCH, J.V. (1987). Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J. Exp. Med. 166, 1084-1097.
23. SAUTY, A., DZIEJMAN, M., TAHA, R.A., IAROSSI, A.S., NEOTE, K., GARCIA-ZEPEDA, E.A., HAMID, Q., and LUSTER, A.D. (1999). The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162, 3549-3558.
24. WEBER, K.S., NELSON, P.J., GRONE, H.J., and WEBER, C. (1999). Expression of CCR2 by endothelial cells: implications for MCP-1-mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler. Thromb. Vasc. Biol. 19, 2085-2093.
25. WUYTS, A., PROOST, P., LENAERTS, J.P., BEN-BARUCH, A., VAN DAMME, J., and WANG, J.M. (1998). Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell- derived neutrophil attractant-78. Eur. J. Biochem. 255, 67-73.
26. BONECCHI, R., BIANCHI, G., BORDIGNON, P.P., D'AMBROSIO, D., LANG, R., BORSATTI, A., SOZZANI, S., ALLAVENA, P., GRAY, P.A., MANTOVANI, A., and SINIGAGLIA, F. (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187, 129-134.
27. COLE, K.E., STRICK, C.A., PARADIS, T.J., OGBORNE, K.T., LOETSCHER, M., GLADUE, R.P., LIN, W., BOYD, J.G., MOSER, B., WOOD, D.E., SAHAGAN, B.G., and NEOTE, K. (1998). Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187, 2009-2021.
28. LILLARD, J.W., Jr., BOYAKA, P.N., HEDRICK, J.A., ZLOTNIK, A., and MCGHEE, J.R. (1999). Lymphotactin acts as an innate mucosal adjuvant. J. Immunol. 162, 1959-1965.
29. LILLARD, J.W., Jr., BOYAKA, P.N., TAUB, D.D., and MCGHEE, J.R. (2001). RANTES potentiates antigen-specific mucosal immune responses. J. Immunol. 166, 162-169.
30. LILLARD, J.W., Jr., SINGH, U.P., BOYAKA, P.N., SINGH, S., TAUB, D.D., and MCGHEE, J.R. (2003). MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. Blood 101, 807-814.
31. LILLARD, J.W., and MCGHEE, J.R. (1997). Adjuvants or live delivery systems for the characterization of mucosal T helper subset responses. Res. Immunol. 148, 520-527.
32. LILLARD, J.W., Jr., BOYAKA, P.N., CHERTOV, O., OPPENHEIM, J.J., and MCGHEE, J.R. (1999). Mechanism for induction of acquired host immunity by neutrophil peptide defensins. Proc. Natl. Acad. Sci. USA 96, 651-656.
33. MARINARO, M., BOYAKA, P.N., FINKELMAN, F.D., KIYONO, H., JACKSON, R.J., JIRILLO, E., and MCGHEE, J.R. (1997). Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 185, 415-427.
34. BOYAKA, P.N., MARINARO, M., JACKSON, R.J., MENON, S., KIYONO, H., JIRILLO, E., and MCGHEE, J.R. (1999). IL-12 is an effective adjuvant for induction of mucosal immunity. J. Immunol. 162, 122-128.
35. LOETSCHER, M., LEGLER, D.F., CLARK-LEWIS, I., BAGGIOLINI, M., and MOSER, B. (1997). Chemokine receptor specific for IP10 and MIG: structure, function, and expression in activated T-lymphocytes. J. Biol. Chem. 272, 17251-17254.
36. YANG, O.O., GARCIA-ZEPEDA, E.A., GE, Y., KALAMS, S.A., WALKER, B.D., PASTERNACK, M.S., and LUSTER, A.D. (1998). Chemokines-chemotactic cytokines that mediate inflammation. Nature 391, 908-911.
37. LOETSCHER, M., PIALI, L., and LOETSCHER, P. (1998). CCR5 is characteristic of Th1 lymphocytes. Int. Rev. Immunol. 16, 323-344.
38. PARDALI, E., SALLUSTO, F., SPELETAS, M., RUEDL, C., SHIMIZU, T., SEIDL, T., ANDERSSON, J., MELCHERS, F., ROLINK, A.C., and SIDERAS, P. (1998). Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 188, 451-463.
39. KARPUS, W.J., and LUKACS, N.W. (1996). The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with anti-monocyte chemotactic protein-1. Ann. NY Acad. Sci. 778, 133-144.
40. KARPUS, W.J., KENNEDY, K.J., KUNKEL, S.L., and LUKACS, N.W. (1998). Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines, J. Exp. Med. 187, 733-741.
41. + T-cell subsets in vivo. Immunol. Rev. 123, 189-207.
42. FINKELMAN, F.D., HOLMES, J., KATONA, I.M., URBAN, J.F., Jr., BECKMANN, M.P., PARK, L.S., SCHOOLEY, K.A., COFFMAN, R.L., MOSMANN, T.R., and PAUL, W.E. (1990). Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8, 303-333.
43. FREEDMAN, A.S., FREEMAN, G.J., RHYNHART, K., and NADLER, L.M. (1991). Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell. Immunol. 137, 429-437.
44. LINSLEY, P.S., CLARK, E.A., and LEDBETTER, J.A. (1990). T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87, 5031-5035.
45. LINSLEY, P.S., BRADY, W., GROSMAIRE, L., ARUFFO, A., DAMLE, N.K., and LEDBETTER, J.A. (1991). Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173, 721-730.
46. GARDBY, E., LANE, P., and LYCKE, N.Y. (1998). Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-H gamma 1 transgenic mice. J. Immunol. 161, 49-59.
47. CONG, Y., WEAVER, C.T., LAZENBY, A., and ELSON, C.O. (2002). Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169, 6112-6119.
48. + T cells correlates with suppression of psoriasis and colitis. Int. Immunopharmacol. 2, 653-672.
49. LIU, Z., GEBOES, K., HELLINGS, P., MAERTEN, P., HEREMANS, H., VANDENBERGHE, P., BOON, L., VAN KOOTEN, P., RUTGEERTS, P., and CEUPPENS, J.L. (2001). B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J. Immunol. 167, 1830-1838.
50. LU, B., HUMBLES, A., BOTA, D., GERARD, C., MOSER, B., SOLER, D., LUSTER, A.D., and GERARD, N.P. (1999). Structure and function of the murine chemokine receptor CXCR3. Eur. J. Immunol. 29, 3804-3812.
51. LUSTER, A.D., GREENBERG, S.M., and LEDER, P. (1995). The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182, 219-231.
52. SOEJIMA, K., and ROLLINS, B.J. (2001), A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J. Immunol. 167, 6576-6582.
53. LOETSCHER, P., PELLEGRINO, A., GONG, J.H., MATTIOLI, I., LOETSCHER, M., BARDI, G., BAGGIOLINI, M., and CLARK-LEWIS, I. (2001). The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J. Biol. Chem. 276, 2986-2991.
54. FORT, M., LESLEY, R., DAVIDSON, N., MENON, S., BROMBACHER, F., LEACH, M., and RENNICK, D. (2001). IL-4 exacerbates disease in a Th1 cell transfer model of colitis. J. Immunol. 166, 2793-2800.
55. high T cells. Eur. J. Immunol. 31, 1465-1474.
56. MATSUMOTO, S., OKABE, Y., SETOYAMA, H., TAKAYAMA, K., OHTSUKA, J., FUNAHASHI, H., IMAOKA, A., OKADA, Y., and UMESAKI, Y. (1998). Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43, 71-78.
57. STROBER, W., NAKAMURA, K., and KITANI, A. (2001). The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease. J. Clin. Invest. 107, 667-670.
58. PIZARRO, T.T., ARSENEAU, K.O., and COMINELLI, F. (2000). Lessons from genetically engineered animal models. XI. Novel mouse models to study pathogenic mechanisms of Crohn's disease. Am. J. Physiol. 278, G665-G669.
59. high T cells to SCID recipients. J. Immunol. 158, 3464-3473.
60. WANG, S.C., SIMMONS, R.L., BILLIAR, T.R., and SCHATTENFROH, N.C. (1995). Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease. J. Leukocyte Biol. 57, 297-302.
61. UGUCCIONI, M., GIONCHETTI, P., ROBBIANI, D.F., RIZZELLO, F., PERUZZO, S., CAMPIERI, M., and BAGGIOLINI, M. (1999). Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am. J. Pathol. 155, 331-336.
62. SHIBAHARA, T., WILCOX, J.N., COUSE, T., and MADARA, J.L. (2001). Characterization of epithelial chemoattractants for human intestinal intraepithelial lymphocytes. Gastroenterology 120, 60-70.
63. SOTO, H., WANG, W., STRIETER, R.M., COPELAND, N.G., GILBERT, D.I., JENKINS, N.A., HEDRICK, J., and ZLOTNIK, A. (1998). The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA 95, 8205-8210.
64. WALZ, A., SCHMUTZ, P., MUELLER, C., and SCHNYDER-CANDRIAN, S. (1997). Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J. Leukocyte Biol. 62, 604-611.
65. DWINELL, M.B., LUGERING, N., ECKMANN, L., and KAGNOFF, M.F. (2001). Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 120, 49-59.w
66. YUAN, Y.H., TEN HOVE, T., THE, F.O., SLORS, J.F., VAN DEVENTER, S.J., and TE VELDE, A.A. (2001). Chemokine receptor CXCR3 expression in inflammatory bowel disease. Inflamm. Bowel Dis. 7, 281-286.